Molecular Formula | C13H11N3O5 |
Molar Mass | 289.24 |
Density | 1.546±0.06 g/cm3(Predicted) |
Melting Point | >250°C (dec.) |
Boling Point | 616.6±55.0 °C(Predicted) |
Flash Point | 326.685°C |
Solubility | DMSO (Slightly, Heated), Methanol (Slightly) |
Vapor Presure | 0mmHg at 25°C |
Appearance | Solid |
Color | Beige to Brown |
pKa | 10.55±0.40(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
Refractive Index | 1.657 |
Use | Intermediate |
Hazard Class | IRRITANT |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.457 ml | 17.287 ml | 34.573 ml |
5 mM | 0.691 ml | 3.457 ml | 6.915 ml |
10 mM | 0.346 ml | 1.729 ml | 3.457 ml |
5 mM | 0.069 ml | 0.346 ml | 0.691 ml |
Use | 3-(4-nitro-1-oxo-1, 3-dihydroisoindol-2-yl) piperidine -2, 6-dione is used as lenalidomide impurity and lenalidomide intermediate. 3-(4-nitro-1-oxo-1, 3-dihydroisoindol-2-yl) piperidin-2, 6-dione is used as lenalidomide impurity, lenalidomide intermediate. |